Pavel Hejsek is a seasoned professional in commercial growth and strategic sales, currently leading AB InBev Biotech's global market expansion efforts. With extensive experience at EverGrain® by AB InBev, Pavel successfully executed large-scale commercialization initiatives and developed product and commercial strategies, contributing to the establishment of a $100M industrial facility. Pavel also held various strategic positions at AB InBev, focusing on investments in circular ventures and long-term renewable trades. Early career experiences include roles in investment banking and financial analysis at Deutsche Bank and Goldin Associates. Pavel holds an MBA from The Wharton School and a B.A. in Economics from Dickinson College, complemented by studies at Sciences Po Toulouse.